在乳腺癌中准TNFR1驱动的亡
Misbahuddin Rafeeq1, Muhammad Afzal2, Muhammad Shahid Nadeem3
1Division of Basic Medical Sciences, College of Medicine, Dhofar University, Oman.
EXCLI journal
|January 26, 2026
概括
瘤亡因子受体1 (TNFR1) 通过亡和其他途径决定乳腺癌细胞的命运. TNFR1激活触发了表观遗传重编程,为癌症治疗提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 瘤坏死因子受体1 (TNFR1) 在乳腺癌细胞存活,亡和亡中至关重要.
- TNFR1信号传递涉及NF-kB,酶-8和RIPK1-RIPK3-MLKL轴等关键通路.
研究的目的:
- 审查TNFR1在乳腺癌细胞死亡途径中的作用,重点关注表观遗传修饰.
- 探索潜在的治疗策略,以TNFR1-necroptosis轴为目标.
主要方法:
- 关于TNFR1信号传递,亡和乳腺癌中的表观遗传调节的文献综述.
- 分析分子机制,包括DNA甲基化,基因素修饰和microRNA控制.
主要成果:
- TNFR1的激活会诱导表观遗传变化 (DNA甲基化,基因组修饰),从而重新编程细胞反应.
- 遗传病死途径涉及RIPK1-RIPK3体形成和MLKL酸化.
- 生物标志物如TNFR1表达和表观遗传标志物被确定为潜在的治疗指导.
结论:
- 由于TNFR1的双重作用,TNFR1信号传递和亡构成复杂的治疗挑战.
- 通过表观遗传策略和生物标志物导向疗法向TNFR1-亡途径,对乳腺癌治疗有希望.
- 需要进一步的研究来解决患者分层问题,并优化治疗序列.
相关概念视频
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
ATP Driven Pumps I: An Overview
9.8K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.8K
ATP Driven Pumps II: P-type Pumps
6.3K
The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
6.3K
Xylem and Transpiration-driven Transport of Resources
26.6K
The xylem of vascular plants distributes water and dissolved minerals that are taken up by the roots to the rest of the plant. The cells that transport xylem sap are dead upon maturity, and the movement of xylem sap is a passive process.
26.6K
ATP Driven Pumps III: V-type Pumps
4.8K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.8K
Cancer
54.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K


